chr3:148415571:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr3:148,415,571-148,460,795 |
| hg38 | chr3:148,697,784-148,743,008 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.002 | Low Cardiac Output | NA | GAD | Detail | |
| 0.080 | Cardiomyopathy, Dilated | NA | BeFree,RGD | Detail | |
| 0.009 | hypertrophic cardiomyopathy | NA | BeFree,GAD,LHGDN | Detail | |
| 0.034 | Cardiovascular Diseases | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Carotid Artery Diseases | NA | GAD | Detail | |
| 0.002 | carotid stenosis | NA | GAD | Detail | |
| <0.001 | Cerebral Embolism | NA | BeFree | Detail | |
| 0.005 | cerebral infarction | NA | BeFree,GAD | Detail | |
| 0.010 | brain ischemia | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | cerebral palsy | NA | GAD | Detail | |
| 0.007 | Cerebrovascular Disorders | NA | GAD | Detail | |
| 0.002 | chorioamnionitis | NA | GAD | Detail | |
| 0.005 | Chromosome Deletion | NA | GAD | Detail | |
| 0.002 | Cicatrization | NA | GAD | Detail | |
| 0.002 | Connective Tissue Diseases | NA | GAD | Detail | |
| 0.002 | Convalescence | NA | GAD | Detail | |
| 0.023 | Coronary Arteriosclerosis | NA | BeFree,GAD | Detail | |
| 0.039 | Coronary heart disease | Our study intended to prove whether agonistic autoantibodies to angiotensin II t... | BeFree,GAD,LHGDN | 25762441 | Detail |
| 0.002 | coronary thrombosis | NA | GAD | Detail | |
| 0.002 | Coughing | NA | GAD | Detail | |
| <0.001 | cystadenoma | NA | BeFree | Detail | |
| 0.003 | Mental Depression | NA | BeFree,GAD | Detail | |
| <0.001 | depressive disorder | NA | BeFree | Detail | |
| 0.003 | Diabetes | NA | BeFree | Detail | |
| 0.009 | diabetes mellitus | NA | BeFree,GAD | Detail | |
| 0.020 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree,GAD | Detail | |
| 0.039 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Diabetic Angiopathies | NA | GAD | Detail | |
| 0.113 | Diabetic Nephropathy | Hypertension connected with renin-angiotensin system (RAS) hyperactivity and cor... | BeFree,GAD,LHGDN,RGD | 25109108 | Detail |
| 0.002 | Diabetic Neuropathies | NA | GAD | Detail | |
| 0.125 | diabetic retinopathy | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| <0.001 | Camurati-Engelmann Syndrome | Positive effects of an angiotensin II type 1 receptor antagonist in Camurati-Eng... | BeFree | 25099136 | Detail |
| <0.001 | Down syndrome | NA | BeFree | Detail | |
| 0.122 | patent ductus arteriosus | NA | CTD_human,GAD | Detail | |
| <0.001 | eclampsia | NA | BeFree | Detail | |
| 0.002 | Edema | NA | GAD | Detail | |
| <0.001 | endometrial hyperplasia | NA | BeFree | Detail | |
| <0.001 | endometriosis | NA | BeFree | Detail | |
| 0.002 | Esophageal Varices | NA | GAD | Detail | |
| <0.001 | Exanthema | NA | BeFree | Detail | |
| 0.003 | Fatty Liver | NA | BeFree,GAD | Detail | |
| 0.002 | Fetal Death | NA | GAD | Detail | |
| 0.080 | Fetal Growth Retardation | NA | RGD | Detail | |
| 0.005 | Fetal Membranes, Premature Rupture | NA | GAD | Detail | |
| 0.002 | Fibromuscular Dysplasia | NA | GAD | Detail | |
| 0.165 | Fibrosis | NA | CTD_mouse,GAD,LHGDN,RGD | Detail | |
| <0.001 | Friedreich ataxia | NA | BeFree | Detail | |
| <0.001 | gastritis | NA | BeFree | Detail | |
| 0.002 | Gastrointestinal Diseases | NA | GAD | Detail | |
| 0.002 | Gastrointestinal Hemorrhage | NA | GAD | Detail | |
| 0.005 | glaucoma | NA | GAD | Detail | |
| 0.003 | glomerulonephritis | NA | BeFree,GAD | Detail | |
| 0.024 | IgA glomerulonephritis | Association of angiotensin II type-1 receptor A1166C gene polymorphism with the ... | BeFree,GAD,LHGDN | 25585948 | Detail |
| 0.083 | Focal glomerulosclerosis | Angiotensin II, acting through its AT1 receptor, plays a critical role in genera... | BeFree,GAD,RGD | 26551740 | Detail |
| 0.002 | Graft-vs-Host Disease | NA | GAD | Detail | |
| 0.002 | congenital heart defects | NA | GAD | Detail | |
| 0.003 | Heart Diseases | NA | BeFree,LHGDN | Detail | |
| 0.168 | Cardiomegaly | NA | CTD_mouse,LHGDN,RGD | Detail | |
| 0.217 | Heart failure | NA | BeFree,CTD_human,GAD,LHGDN,RGD | Detail | |
| 0.003 | congestive heart failure | Endothelial dysfunction was present in CHF group and the presence of ecNOS a all... | BeFree | 24992619 | Detail |
| 0.002 | hemolytic-uremic syndrome | NA | GAD | Detail | |
| 0.080 | Diaphragmatic hernia | NA | CTD_mouse | Detail | |
| 0.003 | Hyperaldosteronism | NA | LHGDN | Detail | |
| 0.011 | Hypercholesterolemia | NA | BeFree,GAD,LHGDN | Detail | |
| 0.005 | Hypercholesterolemia, Familial | NA | BeFree,GAD | Detail | |
| 0.001 | hyperglycemia | NA | BeFree | Detail | |
| 0.080 | hyperinsulinism | NA | BeFree,RGD | Detail | |
| 0.002 | Hyperlipidemia | NA | GAD | Detail | |
| <0.001 | Hypertension, Portal | NA | BeFree | Detail | |
| 0.003 | pulmonary hypertension | NA | BeFree,GAD | Detail | |
| 0.087 | renal hypertension | NA | GAD,RGD | Detail | |
| 0.081 | Hypertension, Renovascular | NA | BeFree,RGD | Detail | |
| 0.002 | hypoglycemia | NA | GAD | Detail | |
| 0.003 | Hypotension, Orthostatic | NA | LHGDN | Detail | |
| 0.002 | Infant, Premature, Diseases | NA | GAD | Detail | |
| 0.003 | Inflammation | NA | LHGDN | Detail | |
| 0.002 | Insulin resistance | NA | GAD | Detail | |
| 0.001 | ischemia | NA | BeFree | Detail | |
| 0.221 | Kidney Diseases | The main roles of Ang II in renal disease are mediated via the Ang type 1 recept... | BeFree,CTD_human,CTD_mouse,GAD | 25148511 | Detail |
| 0.221 | Kidney Diseases | Angiotensin II, acting through its AT1 receptor, plays a critical role in genera... | BeFree,CTD_human,CTD_mouse,GAD | 26551740 | Detail |
| 0.005 | Kidney Failure, Acute | NA | BeFree,GAD | Detail | |
| 0.048 | Kidney Failure, Chronic | NA | BeFree,GAD,LHGDN | Detail | |
| 0.005 | Polycystic Kidney Diseases | NA | BeFree,GAD | Detail | |
| 0.002 | Premature Obstetric Labor | NA | GAD | Detail | |
| 0.002 | Hyperlipoproteinemia Type I | NA | GAD | Detail | |
| 0.003 | liver cirrhosis | NA | BeFree,GAD | Detail | |
| 0.080 | Liver Cirrhosis, Experimental | NA | CTD_mouse | Detail | |
| <0.001 | Alcoholic Liver Diseases | NA | BeFree | Detail | |
| <0.001 | Liver neoplasms | NA | BeFree | Detail | |
| 0.002 | long QT syndrome | NA | GAD | Detail | |
| 0.002 | Chronic Obstructive Airway Disease | NA | GAD | Detail | |
| 0.002 | Lupus Erythematosus, Systemic | NA | GAD | Detail | |
| 0.002 | lupus nephritis | NA | GAD | Detail | |
| <0.001 | Malignant neoplasm of stomach | NA | BeFree | Detail | |
| 0.160 | Mammary Neoplasms, Experimental | NA | CTD_mouse,RGD | Detail | |
| <0.001 | Marfan syndrome | Recently, losartan, an angiotensin II type I receptor antagonist (ARB), has show... | BeFree | 24527681 | Detail |
| <0.001 | Marfan syndrome | By demonstrating that promiscuous AT1r and TGFβ drive partially overlapping proc... | BeFree | 25614286 | Detail |
| <0.001 | melanoma | NA | BeFree | Detail | |
| 0.002 | Meningococcal Infections | NA | GAD | Detail | |
| <0.001 | Metabolic Diseases | NA | BeFree | Detail | |
| <0.001 | Microangiopathy, Diabetic | NA | BeFree | Detail | |
| <0.001 | mitral valve insufficiency | Unraveling regulatory mechanisms of atrial remodeling of mitral regurgitation pi... | BeFree | 25500755 | Detail |
| <0.001 | Mitral Valve Prolapse Syndrome | NA | BeFree | Detail | |
| 0.005 | Mucocutaneous Lymph Node Syndrome | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | Muscle Rigidity | NA | BeFree | Detail | |
| 0.147 | myocardial infarction | A systematic review and meta-analysis of the association between angiotensin II ... | BeFree,GAD,LHGDN,RGD | 23178513 | Detail |
| 0.080 | Myocardial Reperfusion Injury | NA | RGD | Detail | |
| 0.120 | Neoplasm Metastasis | NA | CTD_human | Detail | |
| 0.080 | nephritis | NA | RGD | Detail | |
| 0.003 | Nephritis, Interstitial | NA | BeFree,GAD | Detail | |
| 0.002 | nephrotic syndrome | NA | GAD | Detail | |
| <0.001 | endometriosis | XRCC1 399 Arg-related genotype and allele, but not XRCC1 His107Arg, XRCC1 Trp194... | BeFree | 22084859 | Detail |
| 0.010 | obesity | NA | BeFree,GAD | Detail | |
| 0.003 | otosclerosis | NA | BeFree,GAD | Detail | |
| <0.001 | ovarian carcinoma | NA | BeFree | Detail | |
| 0.003 | Peptic Ulcer | NA | BeFree,GAD | Detail | |
| 0.002 | Peptic Ulcer Hemorrhage | NA | GAD | Detail | |
| 0.002 | periodontitis | NA | GAD | Detail | |
| 0.003 | pheochromocytoma | NA | LHGDN | Detail | |
| 0.120 | Pituitary Neoplasms | NA | CTD_human | Detail | |
| 0.080 | placental insufficiency | NA | RGD | Detail | |
| 0.002 | Postoperative Complications | NA | GAD | Detail | |
| 0.028 | pre-eclampsia | NA | GAD,LHGDN | Detail | |
| 0.002 | Pregnancy Complications, Hematologic | NA | GAD | Detail | |
| 0.207 | proteinuria | NA | CTD_human,GAD,RGD | Detail | |
| 0.005 | pulmonary edema | NA | GAD | Detail | |
| 0.002 | Henoch-Schoenlein purpura | NA | GAD | Detail | |
| 0.002 | renal artery obstruction | NA | GAD | Detail | |
| 0.005 | kidney failure | NA | BeFree,GAD | Detail | |
| <0.001 | Respiratory Distress Syndrome, Adult | NA | BeFree | Detail | |
| 0.002 | Retinal Diseases | NA | GAD | Detail | |
| <0.001 | retinopathy of prematurity | NA | BeFree | Detail | |
| 0.002 | rheumatic heart disease | NA | GAD | Detail | |
| 0.003 | sarcoidosis | NA | BeFree,GAD | Detail | |
| 0.002 | Sarcoidosis, Pulmonary | NA | GAD | Detail | |
| 0.003 | systemic scleroderma | NA | LHGDN | Detail | |
| 0.003 | Stomach Neoplasms | NA | LHGDN | Detail | |
| 0.029 | Cerebrovascular accident | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | subacute sclerosing panencephalitis | NA | BeFree,GAD | Detail | |
| 0.003 | Tachycardia | NA | BeFree,LHGDN | Detail | |
| 0.002 | Tuberculosis, Pulmonary | NA | GAD | Detail | |
| <0.001 | Turner syndrome | NA | BeFree | Detail | |
| 0.002 | uremia | NA | GAD | Detail | |
| 0.002 | urinary tract infection | NA | GAD | Detail | |
| 0.003 | Vascular Diseases | NA | BeFree,GAD | Detail | |
| 0.005 | Vasovagal syncope | NA | GAD | Detail | |
| 0.011 | Vesico-Ureteral Reflux | NA | BeFree,GAD | Detail | |
| 0.003 | AIDS-Associated Nephropathy | NA | BeFree,LHGDN | Detail | |
| <0.001 | Peripheral Vascular Diseases | NA | BeFree | Detail | |
| <0.001 | Ovarian Failure, Premature | NA | BeFree | Detail | |
| 0.002 | Sudden cardiac death | NA | GAD | Detail | |
| 0.039 | Left Ventricular Hypertrophy | NA | BeFree,GAD | Detail | |
| 0.002 | Deep Vein Thrombosis | NA | GAD | Detail | |
| 0.003 | Migraine Disorders | NA | BeFree,GAD | Detail | |
| 0.005 | Premature Birth | NA | GAD | Detail | |
| <0.001 | renal fibrosis | Furthermore, loss of clusterin accelerated Ang II-stimulated renal fibrosis and ... | BeFree | 25148511 | Detail |
| 0.011 | Myocardial Ischemia | NA | BeFree,GAD | Detail | |
| <0.001 | hypertensive heart disease | NA | BeFree | Detail | |
| <0.001 | Idiopathic pulmonary hypertension | Molecular and clinical analysis of TRPC6 and AGTR1 genes in patients with pulmon... | BeFree | 25603901 | Detail |
| 0.002 | Chronic glomerulonephritis | NA | GAD | Detail | |
| <0.001 | migraine with aura | NA | BeFree | Detail | |
| <0.001 | secondary hypertension | NA | BeFree | Detail | |
| 0.002 | acute myocardial infarction | NA | BeFree | Detail | |
| <0.001 | Old myocardial infarction | NA | BeFree | Detail | |
| 0.003 | Cicatrix, Hypertrophic | NA | LHGDN | Detail | |
| 0.133 | Aortic Aneurysm, Abdominal | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| <0.001 | Aortic Aneurysm, Thoracic | By demonstrating that promiscuous AT1r and TGFβ drive partially overlapping proc... | BeFree | 25614286 | Detail |
| <0.001 | Glomerulosclerosis (disorder) | NA | BeFree | Detail | |
| <0.001 | Tumor Progression | NA | BeFree | Detail | |
| <0.001 | adrenal cortical adenoma | NA | BeFree | Detail | |
| <0.001 | adrenocortical carcinoma | NA | BeFree | Detail | |
| 0.080 | Carcinoma, Lobular | NA | CTD_mouse | Detail | |
| <0.001 | Fibrillation | NA | BeFree | Detail | |
| <0.001 | Paroxysmal atrial fibrillation | NA | BeFree | Detail | |
| 0.001 | pancreatic carcinoma | MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 ... | BeFree | 25646808 | Detail |
| <0.001 | Congenital posterior urethral valves | NA | BeFree | Detail | |
| <0.001 | Aortic root dilatation | NA | BeFree | Detail | |
| 0.001 | Fibrosis, Liver | NA | BeFree | Detail | |
| 0.008 | coronary stenosis | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | Dyslipidemias | NA | BeFree,GAD | Detail | |
| 0.003 | age related macular degeneration | NA | BeFree,GAD | Detail | |
| <0.001 | Coronary artery atheroma | NA | BeFree | Detail | |
| 0.001 | Chronic heart failure | NA | BeFree | Detail | |
| <0.001 | Rheumatic disease of heart valve | NA | BeFree | Detail | |
| 0.003 | Chronic Periodontitis | NA | BeFree,GAD | Detail | |
| <0.001 | Renal vascular disorder | NA | BeFree | Detail | |
| 0.080 | Impaired glucose tolerance | NA | CTD_mouse | Detail | |
| <0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
| <0.001 | Very Low Birth Weight | NA | BeFree | Detail | |
| 0.003 | Restenosis | NA | BeFree,GAD | Detail | |
| <0.001 | Infarction, Lacunar | NA | BeFree | Detail | |
| <0.001 | Proliferative retinopathy | NA | BeFree | Detail | |
| <0.001 | High altitude pulmonary edema | NA | BeFree | Detail | |
| <0.001 | Ventricular hypertrophy | NA | BeFree | Detail | |
| <0.001 | Polygenic hypercholesterolemia | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of liver | NA | BeFree | Detail | |
| 0.001 | Malignant neoplasm of pancreas | MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 ... | BeFree | 25646808 | Detail |
| 0.002 | Cardiac Death | NA | GAD | Detail | |
| 0.003 | Malignant neoplasm of prostate | NA | BeFree,GAD | Detail | |
| 0.002 | thrombophilia | NA | GAD | Detail | |
| <0.001 | Non-alcoholic Fatty Liver Disease | NA | BeFree | Detail | |
| 0.081 | Chronic Kidney Insufficiency | NA | BeFree,RGD | Detail | |
| 0.080 | Anti-Glomerular Basement Membrane Disease | NA | RGD | Detail | |
| <0.001 | endometrial carcinoma | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of liver | AT1R expression showed a direct correlation with tumor stage and liver metastasi... | BeFree | 25138435 | Detail |
| <0.001 | Overweight | NA | BeFree | Detail | |
| <0.001 | Peritoneal Fibrosis | NA | BeFree | Detail | |
| 0.015 | Metabolic syndrome X | NA | BeFree,GAD | Detail | |
| 0.003 | Hepatitis C, Chronic | NA | BeFree,GAD | Detail | |
| <0.001 | Fluid overload | NA | BeFree | Detail | |
| <0.001 | Maternal hypertension | NA | BeFree | Detail | |
| <0.001 | Carotid Atherosclerosis | NA | BeFree | Detail | |
| <0.001 | Intraocular pressure disorder | NA | BeFree | Detail | |
| <0.001 | Carcinogenesis | The regulatory roles of TP53 on miRNA-155 and miRNA-125b differentiate the expre... | BeFree | 25186767 | Detail |
| 0.002 | hyperhomocysteinemia | NA | GAD | Detail | |
| 0.001 | prostate carcinoma | NA | BeFree | Detail | |
| 0.080 | Ventricular Remodeling | NA | RGD | Detail | |
| 0.002 | Encounter due to convalescence | NA | GAD | Detail | |
| <0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
| 0.004 | breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
| <0.001 | Congenital muscular dystrophy (disorder) | Our previous study showed treatment with Losartan, an angiotensin II type I rece... | BeFree | 25766329 | Detail |
| <0.001 | stomach carcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
| <0.001 | Dissecting aneurysm of the thoracic aorta | NA | BeFree | Detail | |
| <0.001 | Microalbuminuria | NA | BeFree | Detail | |
| <0.001 | early pregnancy | This study was undertaken to examine changes in the levels of angiogenic factors... | BeFree | 24718301 | Detail |
| <0.001 | brain infarction | NA | BeFree | Detail | |
| <0.001 | Spots on skin | NA | BeFree | Detail | |
| 0.080 | hypertensive nephropathy | NA | RGD | Detail | |
| <0.001 | female breast hyperplasia | NA | BeFree | Detail | |
| 0.010 | Pregnancy associated hypertension | NA | GAD,LHGDN | Detail | |
| 0.003 | Arteriopathic disease | By demonstrating that promiscuous AT1r and TGFβ drive partially overlapping proc... | BeFree,GAD | 25614286 | Detail |
| <0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Endothelial dysfunction | Endothelial dysfunction was present in CHF group and the presence of ecNOS a all... | BeFree | 24992619 | Detail |
| 0.039 | Coronary heart disease | Angiotensin-converting enzyme insertion/deletion (rs4340) and angiotensin II typ... | BeFree | 21722816 | Detail |
| <0.001 | Chronic graft-versus-host disease | NA | BeFree | Detail | |
| 0.003 | Cardiomyopathies | NA | BeFree,GAD | Detail | |
| 0.120 | Carcinoma, Pancreatic Ductal | NA | CTD_human | Detail | |
| <0.001 | Cerebral Ischemia | NA | BeFree | Detail | |
| 0.003 | ovarian neoplasm | NA | BeFree,LHGDN | Detail | |
| 0.003 | Acute coronary syndrome | Autoantibodies targeting AT1 receptor from patients with acute coronary syndrome... | BeFree,GAD | 25762441 | Detail |
| 0.005 | Cardiomyopathy, Hypertrophic, Familial | NA | GAD | Detail | |
| 0.008 | Heart Failure, Diastolic | NA | BeFree,GAD | Detail | |
| <0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
| 0.080 | Ductal Carcinoma | NA | CTD_mouse | Detail | |
| 0.009 | Systemic arterial pressure | NA | GAD | Detail | |
| <0.001 | First myocardial infarction | Three hundred and fifty six patients with first myocardial infarction (MI) were ... | BeFree | 23990179 | Detail |
| <0.001 | Left ventricular systolic dysfunction | We enrolled 109 consecutive patients with left ventricular systolic dysfunction ... | BeFree | 25036270 | Detail |
| 0.003 | postural orthostatic tachycardia syndrome | NA | LHGDN | Detail | |
| <0.001 | Invasive Carcinoma | NA | BeFree | Detail | |
| <0.001 | pancreatic ductal adenocarcinoma | AT1R, but not AT2R, mRNA levels were significantly higher in the PDAC area than ... | BeFree | 25756513 | Detail |
| <0.001 | Endometrial Endometrioid Adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | Conn Syndrome | NA | BeFree | Detail | |
| 0.003 | Mammary Neoplasms | NA | LHGDN | Detail | |
| <0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
| <0.001 | Xenograft Model | NA | BeFree | Detail | |
| 0.002 | colorectal cancer | NA | GAD | Detail | |
| <0.001 | ST segment elevation myocardial infarction | NA | BeFree | Detail | |
| 0.002 | Chronic Kidney Diseases | NA | BeFree | Detail | |
| 0.003 | Renal Insufficiency | NA | BeFree,GAD | Detail | |
| <0.001 | Cirrhosis | NA | BeFree | Detail | |
| <0.001 | Prehypertension | NA | BeFree | Detail | |
| <0.001 | Peripheral Arterial Diseases | NA | BeFree | Detail | |
| <0.001 | Idiopathic Pulmonary Fibrosis | NA | BeFree | Detail | |
| 0.002 | Venous thromboembolism | NA | GAD | Detail | |
| <0.001 | Aortic root dilation | Increased TGF-β signaling and progression of aortic root dilation in Marfan synd... | BeFree | 24398790 | Detail |
| <0.001 | uterine corpus cancer | NA | BeFree | Detail | |
| <0.001 | Extranodal marginal zone B-cell lymphoma | The present study suggests that activation of (P)RR and AT1R is associated with ... | BeFree | 25503453 | Detail |
| 0.032 | coronary artery disease | NA | BeFree,GAD,LHGDN | Detail | |
| 0.007 | Proteinuria Adverse Event | NA | GAD | Detail | |
| <0.001 | Mesial temporal sclerosis | NA | BeFree | Detail | |
| <0.001 | liver carcinoma | NA | BeFree | Detail | |
| 0.003 | Chronic kidney disease stage 5 | NA | BeFree | Detail | |
| 0.002 | Cerebral white matter lesion | NA | GAD | Detail | |
| 0.002 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | NA | GAD | Detail | |
| <0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
| 0.005 | Cerebral Hemorrhage | NA | GAD,LHGDN | Detail | |
| <0.001 | Pulmonary arterial hypertension | Molecular and clinical analysis of TRPC6 and AGTR1 genes in patients with pulmon... | BeFree | 25603901 | Detail |
| 0.002 | Aortic Stiffness | NA | GAD | Detail | |
| <0.001 | Symptomatic carotid artery stenosis | We analyzed 118 carotid plaques from patients with symptomatic carotid artery st... | BeFree | 25046588 | Detail |
| <0.001 | Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia | Molecular and clinical analysis of TRPC6 and AGTR1 genes in patients with pulmon... | BeFree | 25603901 | Detail |
| 0.123 | Spontaneous abortion | NA | CTD_human,LHGDN | Detail | |
| 0.003 | acromegaly | NA | BeFree,GAD | Detail | |
| <0.001 | adenocarcinoma | NA | BeFree | Detail | |
| 0.001 | adenoma | NA | BeFree | Detail | |
| 0.004 | Adrenal Gland Neoplasms | NA | BeFree,LHGDN | Detail | |
| 0.003 | adrenal rest tumor | NA | LHGDN | Detail | |
| 0.009 | Albuminuria | NA | GAD | Detail | |
| 0.007 | Altitude Sickness | NA | GAD | Detail | |
| 0.003 | Alzheimer's disease | Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovasc... | BeFree,GAD | 24807206 | Detail |
| 0.002 | amyotrophic lateral sclerosis | NA | GAD | Detail | |
| <0.001 | Aneurysm | Biochemical evidence-related aneurysm growth with Erk-mediated AT1r signaling, a... | BeFree | 25614286 | Detail |
| 0.002 | Angina, Unstable | NA | GAD | Detail | |
| 0.002 | arteriosclerosis | NA | BeFree | Detail | |
| 0.080 | asthma | NA | RGD | Detail | |
| 0.038 | atherosclerosis | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | atrial fibrillation | NA | GAD | Detail | |
| 0.002 | Chronic Kidney Diseases | The chi-square test and multivariable logistic regression analysis with adjustme... | BeFree | 19406964 | Detail |
| <0.001 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
| 0.011 | Malignant neoplasm of breast | NA | BeFree,GAD | Detail | |
| <0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
| <0.001 | Noninfiltrating Intraductal Carcinoma | NA | BeFree | Detail | |
| <0.001 | renal cell carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our study intended to prove whether agonistic autoantibodies to angiotensin II type 1 receptor (AT1-... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Hypertension connected with renin-angiotensin system (RAS) hyperactivity and corresponding genotypes... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Positive effects of an angiotensin II type 1 receptor antagonist in Camurati-Engelmann disease: a si... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association of angiotensin II type-1 receptor A1166C gene polymorphism with the susceptibility of im... | DisGeNET | Detail |
| Angiotensin II, acting through its AT1 receptor, plays a critical role in generation of proteinuria ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Endothelial dysfunction was present in CHF group and the presence of ecNOS a allele and AT1R C allel... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The main roles of Ang II in renal disease are mediated via the Ang type 1 receptor (AT1R). | DisGeNET | Detail |
| Angiotensin II, acting through its AT1 receptor, plays a critical role in generation of proteinuria ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Recently, losartan, an angiotensin II type I receptor antagonist (ARB), has shown promising results ... | DisGeNET | Detail |
| By demonstrating that promiscuous AT1r and TGFβ drive partially overlapping processes of arterial di... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Unraveling regulatory mechanisms of atrial remodeling of mitral regurgitation pigs by gene expressio... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| A systematic review and meta-analysis of the association between angiotensin II type 1 receptor A116... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| XRCC1 399 Arg-related genotype and allele, but not XRCC1 His107Arg, XRCC1 Trp194Arg, KCNQ2, AT1R, an... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Furthermore, loss of clusterin accelerated Ang II-stimulated renal fibrosis and AT1R expression. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Molecular and clinical analysis of TRPC6 and AGTR1 genes in patients with pulmonary arterial hyperte... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| By demonstrating that promiscuous AT1r and TGFβ drive partially overlapping processes of arterial di... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreat... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreat... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| AT1R expression showed a direct correlation with tumor stage and liver metastasis, whereas AT2R expr... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The regulatory roles of TP53 on miRNA-155 and miRNA-125b differentiate the expressions of AGTR1 and ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our previous study showed treatment with Losartan, an angiotensin II type I receptor antagonist, imp... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This study was undertaken to examine changes in the levels of angiogenic factors and angiotensin II ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| By demonstrating that promiscuous AT1r and TGFβ drive partially overlapping processes of arterial di... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Endothelial dysfunction was present in CHF group and the presence of ecNOS a allele and AT1R C allel... | DisGeNET | Detail |
| Angiotensin-converting enzyme insertion/deletion (rs4340) and angiotensin II type 1 receptor A1166C ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Autoantibodies targeting AT1 receptor from patients with acute coronary syndrome upregulate proinfla... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Three hundred and fifty six patients with first myocardial infarction (MI) were followed up during a... | DisGeNET | Detail |
| We enrolled 109 consecutive patients with left ventricular systolic dysfunction [left ventricular ej... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| AT1R, but not AT2R, mRNA levels were significantly higher in the PDAC area than in the normal pancre... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Increased TGF-β signaling and progression of aortic root dilation in Marfan syndrome can be prevente... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The present study suggests that activation of (P)RR and AT1R is associated with the pathogenesis of ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Molecular and clinical analysis of TRPC6 and AGTR1 genes in patients with pulmonary arterial hyperte... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We analyzed 118 carotid plaques from patients with symptomatic carotid artery stenosis for expressio... | DisGeNET | Detail |
| Molecular and clinical analysis of TRPC6 and AGTR1 genes in patients with pulmonary arterial hyperte... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathologi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Biochemical evidence-related aneurysm growth with Erk-mediated AT1r signaling, and medial degenerati... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The chi-square test and multivariable logistic regression analysis with adjustment for covariates re... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386545546 dbSNP
- Genome
- hg19
- Position
- chr3:148,415,571-148,460,795
- Variant Type
- snv
Genome browser